Janssen Pharmaceuticals has signed a collaboration agreement with the National Taiwan University (NTU) and the university’s hospital (NTUH) to cooperate on developing new drugs for treating hepatitis B. Despite the high success rate of viral suppression achieved by existing medications, the virus is currently incurable.
Chen Ding-shinn (陳定信), chair professor at National Taiwan University Medical College, said that there are more than 350 million people in the world infected with the hepatitis B virus (HBV), 60 to 70 percent of which are in Asia.
Every year, more than 600 thousand people die as a result of complications such as liver cirrhosis and liver cancer caused by the virus.
“HBV can be transmitted prenatally [from mother to child] or by having contact with an infected person. While less than 3 percent of adults infected with the virus develop chronic hepatitis, more than 90 percent of infected newborns do,” Chen said. “Those who have chronic or persistent hepatitis B are at a high risk of developing liver cirrhosis or liver cancer later in life.”
There are about 2.4 million HBV carriers in Taiwan, Chen said, adding that statistics in 2011 showed that deaths attributable to liver cancer ranked No. 2 on the list of leading causes of death for men and women.
“Eighty percent to 90 percent of liver cancer patients had chronic hepatitis B,” he said.
“However, after Taiwan started vaccinating newborns against HBV in 1984, the number of yearly infections has decreased,” Chen said.
While the nation’s vaccination plan is an effective prevention measure, “having better control over the source of infection is still out of reach. Interferon, an approved medication for treating HBV infections is effective in only one-third of patients, while another treatment, nucleoside analogue therapy, inhibits viral replication without completely eliminating the virus.”
The collaboration is intended to develop a treatment to tackle the disease, Jansen, NTU and NTUH said in a joint statement.
Chen Pei-jer (陳培哲), a professor at the Graduate Institute of Clinical Medicine in NTUH’s Medical College and the principal investigator of the collaboration, said the aim is to “accelerate the development of a new hepatitis B drug by combining the resources uniquely held by the respective partners.”
“NTU has been working in this research field for more than 50 years. NTU’s specialization and experience makes it peerless in the fields of drug research and development,” Chen Pei-jer said.
“Janssen has a large collection of compounds as drug candidates. They need a platform to see whether the candidates are safe and effective,” Chen Pei-jer added.
From the mouse model first established by the NTU research team for assaying anti-viral and immune-modulatory activity — an important indication of HBV eradication — and the woodchuck model, which demonstrates HBV activity most similar to that of human HBV, to recent clinical research, Taiwan has always been a leader in the field of HBV treatment, Chen Pei-jer said, adding that NTU’s research was “a complete line from bench to bedside and back.”
“We are aiming to take the lead in developing a new drug to fully eradicate HBV,” the lead investigator said.
The Ministry of Education (MOE) is to launch a new program to encourage international students to stay in Taiwan and explore job opportunities here after graduation, Deputy Minister of Education Yeh Ping-cheng (葉丙成) said on Friday. The government would provide full scholarships for international students to further their studies for two years in Taiwan, so those who want to pursue a master’s degree can consider applying for the program, he said. The fields included are science, technology, engineering, mathematics, semiconductors and finance, Yeh added. The program, called “Intense 2+2,” would also assist international students who completed the two years of further studies in
Former president Tsai Ing-wen (蔡英文) departed for Europe on Friday night, with planned stops in Lithuania and Denmark. Tsai arrived at Taiwan Taoyuan International Airport on Friday night, but did not speak to reporters before departing. Tsai wrote on social media later that the purpose of the trip was to reaffirm the commitment of Taiwanese to working with democratic allies to promote regional security and stability, upholding freedom and democracy, and defending their homeland. She also expressed hope that through joint efforts, Taiwan and Europe would continue to be partners building up economic resilience on the global stage. The former president was to first
Former president Tsai Ing-wen (蔡英文) on Monday called for greater cooperation between Taiwan, Lithuania and the EU to counter threats to information security, including attacks on undersea cables and other critical infrastructure. In a speech at Vilnius University in the Lithuanian capital, Tsai highlighted recent incidents in which vital undersea cables — essential for cross-border data transmission — were severed in the Taiwan Strait and the Baltic Sea over the past year. Taiwanese authorities suspect Chinese sabotage in the incidents near Taiwan’s waters, while EU leaders have said Russia is the likely culprit behind similar breaches in the Baltic. “Taiwan and our European
The Taipei District Court sentenced babysitters Liu Tsai-hsuan (劉彩萱) and Liu Jou-lin (劉若琳) to life and 18 years in prison respectively today for causing the death of a one-year-old boy in December 2023. The Taipei District Prosecutors’ Office said that Liu Tsai-hsuan was entrusted with the care of a one-year-old boy, nicknamed Kai Kai (剴剴), in August 2023 by the Child Welfare League Foundation. From Sept. 1 to Dec. 23 that year, she and her sister Liu Jou-lin allegedly committed acts of abuse against the boy, who was rushed to the hospital with severe injuries on Dec. 24, 2023, but did not
RSS